{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:46:00Z","timestamp":1791049560561,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1051529"],"award-info":[{"award-number":["1051529"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bcp.2015.06.002","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T21:01:00Z","timestamp":1434142860000},"page":"306-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2"],"prefix":"10.1016","volume":"96","author":[{"given":"Sarah E.","family":"Allison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter I.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4233-7619","authenticated-orcid":false,"given":"Michael","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.06.002_bib0200","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges","volume":"12","author":"Steeg","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2015.06.002_bib0205","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B","article-title":"COX-2 is expressed in human pulmonary, colonic, and mammary tumors","volume":"89","author":"Soslow","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2015.06.002_bib0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2015.06.002_bib0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ijc.1376","article-title":"Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis","volume":"93","author":"Rozic","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2015.06.002_bib0220","first-page":"632","article-title":"Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer","volume":"62","author":"Ristim\u00e4ki","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.06.002_bib0225","doi-asserted-by":"crossref","first-page":"22254","DOI":"10.1074\/jbc.M703169200","article-title":"Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products","volume":"282","author":"Wada","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.06.002_bib0230","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2015.06.002_bib0235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-4827(03)00269-6","article-title":"Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells","volume":"289","author":"Timoshenko","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2015.06.002_bib0240","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1073\/pnas.2535911100","article-title":"Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression","volume":"101","author":"Chang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.06.002_bib0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1073\/pnas.0307640100","article-title":"Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.06.002_bib0250","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1038\/sj.onc.1210154","article-title":"COX-2 involvement in breast cancer metastasis to bone","volume":"26","author":"Singh","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2015.06.002_bib0255","doi-asserted-by":"crossref","first-page":"11155","DOI":"10.1074\/jbc.M710038200","article-title":"Cyclooxygenase-2 up-regulates CCR7 via EP2\/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells","volume":"283","author":"Pan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.06.002_bib0260","doi-asserted-by":"crossref","first-page":"33955","DOI":"10.1074\/jbc.M805490200","article-title":"Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription","volume":"283","author":"Subbaramaiah","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.06.002_bib0265","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/labinvest.2012.90","article-title":"Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model","volume":"92","author":"Xin","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bcp.2015.06.002_bib0270","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1073\/pnas.0805171105","article-title":"Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo","volume":"105","author":"Murata","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.06.002_bib0275","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.bbamcr.2009.09.018","article-title":"Prostaglandin F2\u03b1-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway","volume":"1793","author":"Sales","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2015.06.002_bib0280","first-page":"28","article-title":"Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis","volume":"62","author":"Mutoh","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.06.002_bib0285","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1089\/ars.2013.5374","article-title":"Prostacyclin signalling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis","volume":"20","author":"Peshavariya","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2015.06.002_bib0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00121490","article-title":"Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin\/thromboxane A2 system","volume":"1","author":"Honn","year":"1983","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bcp.2015.06.002_bib0295","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF01225263","article-title":"The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinoma","volume":"118","author":"Schirner","year":"1992","journal-title":"J. Cancer. Res. Clin. Oncol."},{"key":"10.1016\/j.bcp.2015.06.002_bib0300","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(02)01607-2","article-title":"Activation of IP and EP3 receptors alters cAMP-dependent cell migration","volume":"444","author":"Blindt","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2015.06.002_bib0305","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1096\/fj.06-7070com","article-title":"Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion","volume":"21","author":"Bondesen","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2015.06.002_bib0310","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1091\/mbc.E11-04-0374","article-title":"Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis","volume":"22","author":"Turner","year":"2011","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.bcp.2015.06.002_bib0315","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1349-7006.2012.02261.x","article-title":"Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner","volume":"103","author":"Osawa","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2015.06.002_bib0320","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1021\/jm300673z","article-title":"Antiproliferative and antimigratory actions of synthetic long chain monounsaturated fatty acids in breast cancer cells that overexpress cyclooxygenase 2","volume":"55","author":"Cui","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2015.06.002_bib0325","first-page":"580","article-title":"Down-regulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: Importance to reduced hepatic content of cytochrome P450 in cholestasis","volume":"22","author":"Chen","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2015.06.002_bib0330","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1042\/bj20021903","article-title":"Role of activator protein-1 in the downregulation of the human CYP2J2 gene in hypoxia","volume":"373","author":"Marden","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2015.06.002_bib0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jss.2006.03.018","article-title":"Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer","volume":"134","author":"Singh","year":"2006","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bcp.2015.06.002_bib0340","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2407-9-188","article-title":"Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature","volume":"9","author":"K\u00f6hrmann","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2015.06.002_bib0345","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.critrevonc.2006.07.001","article-title":"Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic","volume":"61","author":"de Groot","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bcp.2015.06.002_bib0350","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1158\/1078-0432.CCR-05-0275","article-title":"Targeting matrilysin and its impact on tumor growth in vivo: The potential implications in breast cancer therapy","volume":"11","author":"Jiang","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2015.06.002_bib0355","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/0008-5472.CAN-12-3526","article-title":"Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer","volume":"73","author":"LeBeau","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.06.002_bib0360","doi-asserted-by":"crossref","first-page":"12151","DOI":"10.1074\/jbc.M212665200","article-title":"Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases","volume":"278","author":"Fujino","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.06.002_bib0365","doi-asserted-by":"crossref","first-page":"12266","DOI":"10.1074\/jbc.275.16.12266","article-title":"Urokinase plasminogen activator\/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38\u03b1 mitogen-activated protein kinase activity","volume":"275","author":"Huang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.06.002_bib0370","doi-asserted-by":"crossref","first-page":"47901","DOI":"10.1074\/jbc.M107574200","article-title":"\u03b1v integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.06.002_bib0375","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10585-004-3503-x","article-title":"Breast cancer cells with inhibition of p38\u03b1 have decreased MMP-9 activity and exhibit decreased bone metastasis in mice","volume":"21","author":"Suarez-Cuervo","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bcp.2015.06.002_bib0380","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/4735_2007_0245","article-title":"Regulation of tumorigenesis by p38\u03b1 MAP kinase","volume":"20","author":"Dolado","year":"2008","journal-title":"Top. Curr. Genet."},{"key":"10.1016\/j.bcp.2015.06.002_bib0385","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-10-2914","article-title":"Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness","volume":"71","author":"Hong","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.06.002_bib0390","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/annonc\/mdu456","article-title":"Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2","volume":"25","author":"Piccart","year":"2014","journal-title":"Ann. Oncol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215003184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215003184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T17:55:29Z","timestamp":1537552529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215003184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0006295215003184"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.06.002","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}